Biovie Sale Purchase Of Stock vs Change In Cash Analysis

BIVI Stock

USD 2.71 0.11 3.90%

Biovie financial indicator trend analysis is way more than just evaluating Biovie Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biovie Inc is a good investment. Please check the relationship between Biovie Sale Purchase Of Stock and its Change In Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Sale Purchase Of Stock vs Change In Cash

Sale Purchase Of Stock vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biovie Inc Sale Purchase Of Stock account and Change In Cash. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Biovie's Sale Purchase Of Stock and Change In Cash is 0.56. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Biovie Inc, assuming nothing else is changed. The correlation between historical values of Biovie's Sale Purchase Of Stock and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Biovie Inc are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Sale Purchase Of Stock i.e., Biovie's Sale Purchase Of Stock and Change In Cash go up and down completely randomly.

Correlation Coefficient

0.56

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Sale Purchase Of Stock

Change In Cash

Most indicators from Biovie's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biovie Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

As of now, Biovie's Selling General Administrative is increasing as compared to previous years. The Biovie's current Issuance Of Capital Stock is estimated to increase to about 66.9 M, while Enterprise Value Over EBITDA is forecasted to increase to (0.03).

	2021	2022	2024 (projected)
Interest Expense	2.2M	4.3M	1.5M
Depreciation And Amortization	237.4K	266.8K	193.4K

Interest Expense Depreciation And Amortization

Biovie fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Other Current Liab	Net Tangible Assets	Common Stock Shares Outstanding	Non Current Assets Total	Non Currrent Assets Other	Good Will	Other Current Assets	Intangible Assets	Short Long Term Debt Total	Property Plant And Equipment Net	Net Invested Capital	Net Working Capital
Total Assets		0.45	0.73	-0.79	-0.92	0.51	0.95	1.0	-0.33	0.52	0.93	0.61	1.0	-0.23	0.04	0.73	0.68	0.12	-0.07	0.52	0.33	-0.12	0.78	-0.48	0.89	0.84
Total Current Liabilities	0.45		-0.23	-0.22	-0.4	0.32	0.36	0.43	-0.35	0.17	0.36	0.92	0.44	-0.33	0.88	-0.22	0.79	0.19	-0.06	0.44	0.6	0.09	0.32	-0.47	0.05	-0.08
Total Stockholder Equity	0.73	-0.23		-0.72	-0.69	0.41	0.73	0.74	-0.07	0.2	0.72	-0.1	0.73	0.03	-0.64	0.99	0.17	-0.03	-0.05	0.22	-0.15	-0.21	0.52	-0.13	0.94	0.96
Net Debt	-0.79	-0.22	-0.72		0.87	-0.85	-0.91	-0.79	0.31	-0.17	-0.89	-0.28	-0.79	0.18	0.16	-0.76	-0.68	-0.02	0.09	-0.41	-0.31	0.24	-0.5	0.32	-0.87	-0.82
Retained Earnings	-0.92	-0.4	-0.69	0.87		-0.62	-0.95	-0.92	0.4	-0.45	-1.0	-0.54	-0.92	0.31	-0.04	-0.7	-0.69	-0.11	0.08	-0.55	-0.44	0.14	-0.85	0.53	-0.85	-0.81
Accounts Payable	0.51	0.32	0.41	-0.85	-0.62		0.65	0.49	-0.23	-0.21	0.64	0.21	0.49	-0.1	0.02	0.45	0.72	0.23	0.04	0.49	0.36	-0.01	0.17	-0.4	0.58	0.48
Cash	0.95	0.36	0.73	-0.91	-0.95	0.65		0.96	-0.36	0.49	0.96	0.53	0.96	-0.25	-0.03	0.75	0.7	0.05	-0.08	0.46	0.36	-0.21	0.71	-0.42	0.92	0.88
Cash And Short Term Investments	1.0	0.43	0.74	-0.79	-0.92	0.49	0.96		-0.35	0.51	0.93	0.6	1.0	-0.25	0.02	0.74	0.66	0.03	-0.08	0.45	0.29	-0.2	0.77	-0.42	0.9	0.85
Common Stock Total Equity	-0.33	-0.35	-0.07	0.31	0.4	-0.23	-0.36	-0.35		-0.18	-0.39	-0.39	-0.34	0.99	-0.27	-0.1	-0.15	0.16	0.02	0.0	0.2	0.24	-0.34	-0.05	-0.21	-0.17
Non Current Liabilities Total	0.52	0.17	0.2	-0.17	-0.45	-0.21	0.49	0.51	-0.18		0.43	0.55	0.51	-0.19	0.13	0.17	0.18	0.1	0.01	0.29	0.32	0.03	0.66	-0.35	0.32	0.4
Other Stockholder Equity	0.93	0.36	0.72	-0.89	-1.0	0.64	0.96	0.93	-0.39	0.43		0.5	0.93	-0.29	-0.01	0.73	0.67	0.1	-0.08	0.53	0.4	-0.15	0.83	-0.51	0.87	0.84
Total Liab	0.61	0.92	-0.1	-0.28	-0.54	0.21	0.53	0.6	-0.39	0.55	0.5		0.6	-0.37	0.79	-0.09	0.76	0.2	-0.04	0.49	0.63	0.07	0.55	-0.54	0.2	0.12
Total Current Assets	1.0	0.44	0.73	-0.79	-0.92	0.49	0.96	1.0	-0.34	0.51	0.93	0.6		-0.25	0.03	0.74	0.66	0.04	-0.08	0.45	0.3	-0.2	0.77	-0.43	0.89	0.85
Common Stock	-0.23	-0.33	0.03	0.18	0.31	-0.1	-0.25	-0.25	0.99	-0.19	-0.29	-0.37	-0.25		-0.29	0.0	-0.06	0.17	0.01	0.05	0.24	0.22	-0.31	-0.09	-0.1	-0.07
Other Current Liab	0.04	0.88	-0.64	0.16	-0.04	0.02	-0.03	0.02	-0.27	0.13	-0.01	0.79	0.03	-0.29		-0.63	0.54	0.18	-0.05	0.26	0.58	0.17	0.1	-0.34	-0.39	-0.49
Net Tangible Assets	0.73	-0.22	0.99	-0.76	-0.7	0.45	0.75	0.74	-0.1	0.17	0.73	-0.09	0.74	0.0	-0.63		0.19	-0.11	-0.06	0.16	-0.15	-0.3	0.5	-0.08	0.95	0.96
Common Stock Shares Outstanding	0.68	0.79	0.17	-0.68	-0.69	0.72	0.7	0.66	-0.15	0.18	0.67	0.76	0.66	-0.06	0.54	0.19		0.22	-0.09	0.58	0.76	0.0	0.4	-0.58	0.45	0.33
Non Current Assets Total	0.12	0.19	-0.03	-0.02	-0.11	0.23	0.05	0.03	0.16	0.1	0.1	0.2	0.04	0.17	0.18	-0.11	0.22		0.09	0.87	0.34	0.96	0.12	-0.65	-0.02	-0.03
Non Currrent Assets Other	-0.07	-0.06	-0.05	0.09	0.08	0.04	-0.08	-0.08	0.02	0.01	-0.08	-0.04	-0.08	0.01	-0.05	-0.06	-0.09	0.09		0.08	-0.11	0.1	-0.06	-0.46	-0.05	-0.05
Good Will	0.52	0.44	0.22	-0.41	-0.55	0.49	0.46	0.45	0.0	0.29	0.53	0.49	0.45	0.05	0.26	0.16	0.58	0.87	0.08		0.59	0.73	0.49	-0.86	0.33	0.29
Other Current Assets	0.33	0.6	-0.15	-0.31	-0.44	0.36	0.36	0.29	0.2	0.32	0.4	0.63	0.3	0.24	0.58	-0.15	0.76	0.34	-0.11	0.59		0.21	0.4	-0.66	0.07	0.02
Intangible Assets	-0.12	0.09	-0.21	0.24	0.14	-0.01	-0.21	-0.2	0.24	0.03	-0.15	0.07	-0.2	0.22	0.17	-0.3	0.0	0.96	0.1	0.73	0.21		-0.03	-0.52	-0.25	-0.25
Short Long Term Debt Total	0.78	0.32	0.52	-0.5	-0.85	0.17	0.71	0.77	-0.34	0.66	0.83	0.55	0.77	-0.31	0.1	0.5	0.4	0.12	-0.06	0.49	0.4	-0.03		-0.55	0.6	0.63
Property Plant And Equipment Net	-0.48	-0.47	-0.13	0.32	0.53	-0.4	-0.42	-0.42	-0.05	-0.35	-0.51	-0.54	-0.43	-0.09	-0.34	-0.08	-0.58	-0.65	-0.46	-0.86	-0.66	-0.52	-0.55		-0.26	-0.22
Net Invested Capital	0.89	0.05	0.94	-0.87	-0.85	0.58	0.92	0.9	-0.21	0.32	0.87	0.2	0.89	-0.1	-0.39	0.95	0.45	-0.02	-0.05	0.33	0.07	-0.25	0.6	-0.26		0.98
Net Working Capital	0.84	-0.08	0.96	-0.82	-0.81	0.48	0.88	0.85	-0.17	0.4	0.84	0.12	0.85	-0.07	-0.49	0.96	0.33	-0.03	-0.05	0.29	0.02	-0.25	0.63	-0.22	0.98

Click cells to compare fundamentals

Biovie Account Relationship Matchups

Biovie fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.1M	6.0M	20.1M	35.1M	25.2M	26.5M
Total Current Liabilities	23.5M	996.4K	4.2M	14.5M	9.4M	5.1M
Total Stockholder Equity	(21.5M)	5.1M	3.7M	15.3M	15.5M	16.3M
Net Debt	873.8K	(4.5M)	(6.4M)	(5.0M)	(17.7M)	(16.8M)
Retained Earnings	(41.0M)	(224.9M)	(251.0M)	(301.2M)	(334.2M)	(317.5M)
Accounts Payable	1.3M	996.4K	2.4K	3.5K	3.6M	3.8M
Cash	37.2K	4.5M	18.6M	19.5M	23.8M	25.0M
Cash And Short Term Investments	37.2K	4.5M	18.6M	33.9M	23.8M	25.0M
Common Stock Total Equity	50.7K	520.0	2.2K	2.5K	2.2K	2.1K
Liabilities And Stockholders Equity	2.1M	6.0M	20.1M	35.1M	25.2M	26.5M
Non Current Liabilities Total	62.5K	0.0	12.3M	5.3M	349.9K	332.4K
Other Stockholder Equity	19.5M	229.9M	254.6M	316.4M	349.7M	367.2M
Total Liab	23.6M	996.4K	16.4M	19.8M	9.7M	6.9M
Total Current Assets	413.0K	4.6M	18.8M	34.0M	24.0M	25.3M
Common Stock	520.0	2.2K	2.5K	3.6K	6.2K	8.0K
Other Current Liab	21.4M	996.4K	4.1M	5.3M	3.8K	3.6K
Net Tangible Assets	(23.2M)	3.6M	2.5M	14.4M	16.5M	17.3M
Common Stock Shares Outstanding	4.9M	1.2M	2.5M	3.2M	4.5M	4.7M
Non Current Assets Total	1.7M	1.4M	1.3M	1.1M	1.2M	1.3M
Other Current Assets	375.8K	187.0K	275.8K	102.5K	204.4K	163.7K
Intangible Assets	1.3M	1.1M	866.5K	637.1K	407.7K	387.3K
Net Invested Capital	(20.6M)	5.1M	15.8M	29.7M	34.1M	35.8M
Net Working Capital	(23.1M)	3.6M	14.6M	19.5M	22.5M	23.6M
Capital Stock	520.0	2.2K	2.5K	3.6K	3.3K	3.1K

Currently Active Assets on Macroaxis

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C
MSFT	Microsoft
GM	General Motors

When determining whether Biovie Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biovie's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biovie Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biovie Inc Stock:

How To Invest In Biovie

Details

Is Biovie Stock a good investment?

Details

What is Biovie's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.08)

Return On Assets

(0.67)

Return On Equity

(2.08)

The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biovie Sale Purchase Of Stock vs Change In Cash Analysis

Sale Purchase Of Stock vs Change In Cash

Sale Purchase Of Stock vs Change In Cash Correlation Analysis

Correlation Coefficient

Sale Purchase Of Stock

Change In Cash

Biovie fundamental ratios Correlations

Biovie Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biovie fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Total Equity
Net Working Capital	+ 0.98	Net Invested Capital

Other Stockholder Equity	- 1.0	Retained Earnings
Cash	- 0.95	Retained Earnings
Total Current Assets	- 0.92	Retained Earnings
Cash And Short Term Investments	- 0.92	Retained Earnings
Retained Earnings	- 0.92	Total Assets
Cash	- 0.91	Net Debt